Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Insulet donates $10,000 each to ADA and JDRF to improve lives of people living with diabetes

Insulet Corporation, the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, today announced that is has donated $10,000 each to the American Diabetes Association and the Juvenile Diabetes Research Foundation.

19 Jan 2016

PK molecule could be a target for vascular complications linked to type 1 diabetes

In an article published ahead of print on November 24, 2015 in the journal Diabetes (available at http://dx.doi.org/10.2337/db15-0930), researchers from the Medical University of South Carolina, the American University of Beirut, and Case Western Reserve University report that a molecule called pre-kallikrein (PK) could be a target for the vascular complications associated with type 1 diabetes.

18 Jan 2016

UT Southwestern pediatric researchers identify key trigger of neonatal lung disease

Pediatric researchers at UT Southwestern Medical Center have identified a key component of the pathogenesis of bronchopulmonary dysplasia (BPD), a devastating and sometimes fatal lung disease that affects premature infants. Their findings clarify what prompts the inflammatory response that results in BPD, which previously had been unclear.

18 Jan 2016

Scientists find new way to re-engineer body’s immune system to target cancer

Scientists have demonstrated a new way of re-engineering the body’s immune system to target cancer, paving the way for a new generation of drugs, unprecedented in safety and effectiveness.

18 Jan 2016

MGH researchers find how metformin drug prevents progression of pancreatic cancer

Massachusetts General Hospital investigators may have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer.

17 Jan 2016

Increasing levels of FGF21 hormone protects against loss of immune function in the elderly

A hormone that extends lifespan in mice by 40% is produced by specialized cells in the thymus gland, according to a new study by Yale School of Medicine researchers. The team also found that increasing the levels of this hormone, called FGF21, protects against the loss of immune function that comes with age.

12 Jan 2016

Coordinated care approach to diabetes self-management benefits underserved adult populations

Even in communities with barriers to health care, exercise opportunities and healthy food, residents with diabetes saw improved health outcomes when they participated in programs that took a coordinated care approach to diabetes self-management.

12 Jan 2016

Cancer concerns over chromium diet pills

Concerns have been raised over the long-term use of nutritional supplements containing chromium, after an Australian research team found the supplement is partially converted into a carcinogenic form when it enters cells.

12 Jan 2016

Genetic factors in puberty timing: an interview with Dr John Perry

The study focused on the genetic regions that influence age at voice breaking - a distinct developmental milestone that happens to young men as their larynx (voice box) lengthens when exposed to male hormones.

11 Jan 2016

Reducing sugar in sweetened drinks could prevent 300,000 diabetes cases

A new study published in The Lancet Diabetes & Endocrinology journal suggests that reducing sugar content in sugar sweetened drinks (including fruit juices) in the UK by 40% over five years, without replacing them with any artificial sweeteners, could prevent 500,000 cases of overweight and 1 million cases of obesity, in turn preventing around 300,000 cases of type 2 diabetes, over two decades.

8 Jan 2016

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients.

7 Jan 2016

Sugar tax cuts sugary drinks sales by 12% in Mexico

A 10% tax on sugar-sweetened drinks in Mexico has been associated with a 12% cut in sales just one year after its implementation, according to a study published in The BMJ. The sugar tax was also associated with a 4% increase in the purchase of untaxed beverages.

7 Jan 2016

Insulin-producing cells' mitochondria may represent useful therapeutic target in type 2 diabetes

Factors in the blood from calorie-restricted rats can modify energy-producing mitochondria within the insulin-producing cells that regulate blood sugar levels, new research shows. This has a positive impact on glucose-stimulated insulin secretion and protects cells from fatty acid and glucose toxicity.

7 Jan 2016

Obese young people can still avoid diabetes risk if they lose weight before middle age

Obese young people can still turn their chances of developing life threatening illness around if they change before middle age, says new research.

6 Jan 2016

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

Researchers have identified a mechanism that allows cancer cells to respond and grow rapidly when levels of sugar in the blood rise. This may help to explain why people who develop conditions in which they have chronically high sugar levels in their blood, such as obesity, also have an increased risk of developing certain types of cancer.

6 Jan 2016

UVA-developed artificial pancreas system to undergo final testing in two clinical trials

A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning in early 2016.

5 Jan 2016

Researchers to undertake long-term clinical trial of artificial pancreas system for type 1 diabetes patients

Researchers will soon undertake one of the largest-ever long-term clinical trials of a system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus. If the so-called artificial pancreas system performs in patients as hoped, it could lead to commercial trials and eventual regulatory approval in the United States and abroad.

5 Jan 2016

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Insulet donates $10,000 each to ADA and JDRF to improve lives of people living with diabetes

PK molecule could be a target for vascular complications linked to type 1 diabetes

UT Southwestern pediatric researchers identify key trigger of neonatal lung disease

Scientists find new way to re-engineer body’s immune system to target cancer

MGH researchers find how metformin drug prevents progression of pancreatic cancer

Increasing levels of FGF21 hormone protects against loss of immune function in the elderly

Coordinated care approach to diabetes self-management benefits underserved adult populations

Cancer concerns over chromium diet pills

Genetic factors in puberty timing: an interview with Dr John Perry

Reducing sugar in sweetened drinks could prevent 300,000 diabetes cases

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

Sugar tax cuts sugary drinks sales by 12% in Mexico

Insulin-producing cells' mitochondria may represent useful therapeutic target in type 2 diabetes

Obese young people can still avoid diabetes risk if they lose weight before middle age

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

UVA-developed artificial pancreas system to undergo final testing in two clinical trials

Researchers to undertake long-term clinical trial of artificial pancreas system for type 1 diabetes patients

Diet-to-Go launches new meal plan for individuals with Type 2 diabetes or prediabetes

MUSC researchers receive $1.68 million NIH grant to study better treatment for chronic pancreatitis, diabetes

Processed foods may increase likelihood of developing autoimmune diseases

Mastering RNA extraction for plant and fungal research – eBook eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Newsletters you may be interested in